Form 4 for TWST Twist Bioscience Corp
Accepted 2023-05-08 00:00:00 ET · period of report 2023-05-04 · accession 0001214659-23-006627 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-08 | 2023-05-04 | TWST | Leproust Emily M. | CEO, Dir | M - OptEx | $5.95 | +24.4K | 256.1K | +11% | +$144.9K |
| D | 2023-05-08 | 2023-05-04 | TWST | Leproust Emily M. | CEO, Dir | M - OptEx | $0.00 | +24.4K | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-04 | M | A | 24,360 | $5.95 | 256,094 | D | — | — | |
| 2 | Derivative | Employee Stock Option (right to buy) | 2023-05-04 | M | A | 24,360 | $0.00 | 0 | D | $5.95 · — to 2025-09-28 | 24,360 Common Stock | (F4) The option is immediately exercisable. 25% of the shares subject to the option vested on September 1, 2016 and 1/48th of the shares subject to the option vest on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date. |